Try our beta test site
IMPORTANT: Listing of a study on this site does not reflect endorsement by the National Institutes of Health. Talk with a trusted healthcare professional before volunteering for a study. Read more...
8 studies found for:    Open Studies | "Norovirus"
Show Display Options
RSS Create an RSS feed from your search for:
Open Studies | "Norovirus"
Need help? See RSS Feeds
Choose a feed type:
Show studies that were first received in the last 14 daysShow studies that were first received in the last 14 days
Show studies added or modified in the last 14 daysShow studies that were added or modified in the last 14 days
Rank Status Study
1 Recruiting Long-Term Immunogenicity of the Norovirus GI.I/GII.4 Bivalent Virus-Like Particle (VLP) Vaccine in Adults
Condition: Norovirus
Intervention: Biological: NoV GI.1/GII.4 Bivalent VLP Vaccine
2 Recruiting Optimal Human Dose for GII.2 Norovirus (Snow Mountain) Challenge Studies
Condition: Gastroenteritis Norovirus
Interventions: Biological: Norovirus GII.2 Challenge;   Other: Placebo
3 Recruiting Safety and Immunogenicity of Norovirus GI.1/GII.4 Bivalent VLP Vaccine in Children
Condition: Norovirus
Interventions: Biological: GI.1/GII.4 (15/15);   Biological: GI.1/GII.4 (15/50);   Biological: GI.1/GII.4 (50/50);   Biological: GI.1/GII.4 (50/150);   Drug: Placebo
4 Recruiting Human Breastmilk in Young Children With Norovirus Infection of the Gut
Condition: Norovirus Infections
Intervention: Biological: Donor Breastmilk
5 Recruiting Dose-Optimization Trial of VXA-G1.1-NN in Healthy Volunteers
Condition: Norovirus Gastroenteritis
Intervention: Biological: VXA-G1.1-NN Oral Vaccine
6 Recruiting A Multi-Site Clinical Evaluation of the ARIES Norovirus Assay
Condition: Acute Gastroenteritis
Intervention:
7 Recruiting Efficacy and Immunogenicity of Norovirus GI.1/GII.4 Bivalent Virus-like Particle Vaccine in Adults
Condition: Healthy Volunteers
Interventions: Biological: NoV GI.1/GII.4 Bivalent VLP Vaccine;   Biological: NoV vaccine placebo
8 Recruiting NOV120401 (CKD-516 Tablet) for Advanced Solid Tumors
Condition: Advanced Refractory Solid Tumors
Intervention: Drug: NOV120401

Study has passed its completion date and status has not been verified in more than two years.